Condition
Hepatocellular Cancer (HCC)
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
1Total
P 1 (1)
Trial Status
Recruiting2
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07321613CompletedPrimary
Effect of TCC Cocktail Combined With TACE Versus TACE Alone on Survival in uHCC Patients
NCT07010198RecruitingPrimary
Head-to-Head Comparison of Hepatocellular Cancer (HCC) Screening Strategies: A Prospective Population-Based Cohort Study in Zhongshan City
NCT06711211Recruiting
Spanish Registry of Digestive Tumours RETUD
NCT02690350Phase 1Terminated
An Open Study Assessing the Safety and Tolerability of U3-1784
Showing all 4 trials